The microdosing approach to retatrutide has gained attention precisely because it minimizes side effects including heart rate changes
GLP-1-RA such as liraglutide [4], semaglutide [5], and the dual agonist tirzepatide [6], activating both the GLP1- and the gastric-inhibitory polypeptide receptor (GIP-R), have been shown to significantly reduce body weight, making them a promising therapeutic option for the treatment of obesity
Most researchers switch from one to the other rather than running both
However, there is one major difference that separates retatrutide from tirzepatide: retatrutide targets three hormone receptors, while tirzepatide targets two
However, its important to point out that many of the suggested health benefits from Grns are most likely due to a nutrient-deficient body receiving the necessary vitamins and minerals the gummies provide
GLP-1: Key to Metabolic Health GLP-1 is a hormone produced in the small intestine that helps regulate key metabolic functions, such as stimulating insulin release, suppressing glucagon, and promoting satiety
